...
首页> 外文期刊>The Journal of arthroplasty >No Additional Benefit With Use of a Fibrin Sealant to Decrease Peri-Operative Blood Loss During Primary Total Knee Arthroplasty
【24h】

No Additional Benefit With Use of a Fibrin Sealant to Decrease Peri-Operative Blood Loss During Primary Total Knee Arthroplasty

机译:在首次全膝关节置换术期间使用纤维蛋白密封剂减少围手术期失血没有额外好处

获取原文
获取原文并翻译 | 示例
           

摘要

Blood loss remains a substantial problem associated TKA. This study evaluated the efficacy of a fibrin sealant on: (1) blood loss; (2) blood transfusions; and (3) length of stay. We evaluated the records of 113 consecutive patients with sealant and 70 without sealant. There was no significant difference in the hemoglobin levels (all 9.5-10 g/dL) on each of three postoperative days. There was also no significant difference in the intraoperative blood loss, postoperative blood loss or the total perioperative blood loss in both groups. The mean requirement in each patient was 2.5 +/- 2.4 units in the fibrin sealant group compared to 2.0 +/- 0.8 units in the non-fibrin sealant group. We have stopped using fibrin sealant based on this study. (C) 2014 Elsevier Inc. All rights reserved.
机译:失血仍然是与TKA相关的重大问题。这项研究评估了纤维蛋白封闭剂在以下方面的功效:(1)失血; (2)输血; (3)停留时间。我们评估了连续113例有密封剂的患者和70例无密封剂的患者的记录。术后三天中每天的血红蛋白水平(均为9.5-10 g / dL)无显着差异。两组的术中失血量,术后失血量或围手术期总失血量也无显着差异。纤维蛋白封闭剂组每位患者的平均需求量为2.5 +/- 2.4单位,而非纤维蛋白封闭剂组为2.0 +/- 0.8单位。根据这项研究,我们已停止使用血纤蛋白封闭剂。 (C)2014 Elsevier Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号